Peripheral blood cytopenia before treatment in HCV patients: is it a limitation for HCV treatment in the era of DAA?

被引：2
|
作者：
Bourliere, Marc [1 ]
机构：
[1] St Joseph Hosp, Dept Hepatogastroenterol, Marseille, France
来源：
LIVER INTERNATIONAL | 2012年 / 32卷 / 07期
关键词：
HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; PEGINTERFERON/RIBAVIRIN TREATMENT FAILURE; TELAPREVIR COMBINATION TREATMENT; RIBAVIRIN DOSE REDUCTION; GENOTYPE; CIRRHOTIC-PATIENTS; TREATMENT-NAIVE; BOCEPREVIR; ANEMIA;
D O I：
10.1111/j.1478-3231.2012.02835.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1033 / 1036
页数：4
相关论文
共 50 条
  • [1] Treatment and re-treatment results of HCV patients in the DAA era
    Piecha, Felix
    Gaenssler, Jan-Michael
    Ozga, Ann-Kathrin
    Wehmeyer, Malte H.
    Dietz, Julia
    Kluwe, Johannes
    Laschtowitz, Alena
    von Felden, Johann
    Sterneck, Martina
    Jordan, Sabine
    Pischke, Sven
    Lohse, Ansgar W.
    zur Wiesch, Julian Schulze
    PLOS ONE, 2020, 15 (05):
  • [2] Treatment of HCV in the DAA era: the impact of a multidisciplinary team
    Chervenak, Amy E.
    Aqel, Bashar
    Byrne, Thomas J.
    Carey, Elizabeth J.
    Rakela, Jorge
    Harte, Lorrie A.
    Gallegos-Orozco, Juan F.
    Sapola, Amy M.
    Vargas, Hugo E.
    HEPATOLOGY, 2012, 56 : 228A - 228A
  • [3] Treatment of HIV/HCV co-infection in the DAA era
    Rockstroh, J. K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S20 - S21
  • [4] HCC recurrence after DAA treatment in HCV patients
    Guarino, Maria
    Bruzzese, Dario
    Di Costanzo, Giovan Giuseppe
    Guarracino, Marco
    Morando, Federica
    Sessa, Anna
    Rinaldi, Luca
    Persico, Marcello
    Megna, Angelo Salomone
    Nicola, Coppola
    Cossiga, Valentina
    Caporaso, Nicola
    Morisco, Filomena
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E835 - E836
  • [5] HCC RECURRENCE AFTER DAA TREATMENT IN HCV PATIENTS
    Guarino, M.
    Bruzzese, D.
    Di Costanzo, G. G.
    Guarracino, M.
    Morando, F.
    Sessa, A.
    Rinaldi, L.
    Persico, M.
    Megna, A. Salomone
    Coppola, N.
    Caporaso, N.
    Morisco, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E95 - E95
  • [6] HCC recurrence after DAA treatment in HCV patients
    Guarino, M.
    Bruzzese, D.
    Di Costanzo, G. G.
    Guarracino, M.
    Morando, F.
    Rinaldi, L.
    Persico, M.
    Megna, A. Salomone
    Coppola, N.
    Caporaso, N.
    Morisco, F.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 50 - 50
  • [7] Acute HCV Treatment: What Should We Do in the DAA Era?
    Lominadze Z.
    Brown R.S., Jr.
    Current Hepatology Reports, 2019, 18 (2) : 216 - 221
  • [8] Differential peripheral immune responses during DAA treatment in HCV patients that develop HCC
    Debes, J. D.
    vanTilborg, M.
    Groothuismink, Z.
    deKnegt, R.
    Boonstra, A.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 9 - 9
  • [9] Resistance Associated Mutations in HCV Patients Failing DAA Treatment
    Di Stefano, Mariantonietta
    Faleo, Giuseppina
    Mohamed, Ahmed Mohamed Farhan
    Morella, Simona
    Bruno, Serena Rita
    Tundo, Paolo
    Fiore, Jose Ramon
    Santantonio, Teresa Antonia
    NEW MICROBIOLOGICA, 2021, 44 (01): : 12 - 18
  • [10] Hope and Hopelessness in HCV patients in the era of DAA therapy
    Afdhal, Sophie K.
    Penn, Michael
    Younossi, Zobair M.
    Curry, Michael P.
    HEPATOLOGY, 2015, 62 : 791A - 792A
12345